Cargando…

Is the Level of Contrast Enhancement on Contrast-Enhanced Mammography (CEM) Associated with the Presence and Biological Aggressiveness of Breast Cancer?

There is limited information about whether the level of enhancement on contrast-enhanced mammography (CEM) can be used to predict malignancy. The purpose of this study was to correlate the level of enhancement with the presence of malignancy and breast cancer (BC) aggressiveness on CEM. This IRB-app...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marzogi, Alaa, Baltzer, Pascal A. T., Kapetas, Panagiotis, Milos, Ruxandra I., Bernathova, Maria, Helbich, Thomas H., Clauser, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955826/ https://www.ncbi.nlm.nih.gov/pubmed/36832242 http://dx.doi.org/10.3390/diagnostics13040754

Ejemplares similares

Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
por: Clauser, Paola, et al.
Publicado: (2020)

The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams
por: Milos, Ruxandra Iulia, et al.
Publicado: (2020)

Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis
por: Fueger, Barbara J., et al.
Publicado: (2021)

Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018)

One view or two views for wide-angle tomosynthesis with synthetic mammography in the assessment setting?
por: Clauser, Paola, et al.
Publicado: (2021)

An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies
por: Pötsch, Nina, et al.
Publicado: (2021)

Contrast Enhanced Mammography (CEM) Enhancing Asymmetry: Single-Center First Case Analysis
por: Migliaro, Giuliano, et al.
Publicado: (2023)

Virtual Touch IQ elastography reduces unnecessary breast biopsies by applying quantitative “rule-in” and “rule-out” threshold values
por: Kapetas, Panagiotis, et al.
Publicado: (2018)

A Simple Ultrasound Based Classification Algorithm Allows Differentiation of Benign from Malignant Breast Lesions by Using Only Quantitative Parameters
por: Kapetas, Panagiotis, et al.
Publicado: (2018)

Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes
por: Luczynska, Elzbieta, et al.
Publicado: (2022)

Persistent post-galactogram intraductal iodinated contrast detected on contrast-enhanced mammography (CEM) in a patient with nipple discharge
por: Chen, Shao Zun, et al.
Publicado: (2022)

Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI
por: Avendano, Daly, et al.
Publicado: (2019)

Predicting Malignancy of Breast Imaging Findings Using Quantitative Analysis of Contrast-Enhanced Mammography (CEM)
por: Miller, Matthew M., et al.
Publicado: (2023)

Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions—a feasibility study
por: Åhsberg, Kristina, et al.
Publicado: (2020)

Identifying factors that may influence the classification performance of radiomics models using contrast-enhanced mammography (CEM) images
por: Sun, Yuqi, et al.
Publicado: (2022)

Breast MRI: does a clinical decision algorithm outweigh reader experience?
por: Pötsch, Nina, et al.
Publicado: (2022)

Non-Invasive Assessment of Hypoxia and Neovascularization with MRI for Identification of Aggressive Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2020)

Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging
por: Taylor, Donna B., et al.
Publicado: (2023)

Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI)
por: Barra, Filipe Ramos, et al.
Publicado: (2018)

Contrast enhanced and dual energy mammography
por: Yaffe, MJ
Publicado: (2008)

Artifact reduction in contrast-enhanced mammography
por: Gennaro, Gisella, et al.
Publicado: (2022)

Prospective validation of 18F-Fluoroethylcholine as a tracer in PET/MRI for the evaluation of breast lesions and prediction of lymph node status
por: Clauser, Paola, et al.
Publicado: (2023)

Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI
por: Sodano, Claudia, et al.
Publicado: (2020)

New diagnostic tools for breast cancer
por: Baltzer, Pascal A. T., et al.
Publicado: (2017)

Quantitative Breast Density in Contrast-Enhanced Mammography
por: Gennaro, Gisella, et al.
Publicado: (2021)

Contrast-Enhanced Mammography in the Diagnosis of Breast Angiosarcoma
por: Kacen, Maya Grisaru, et al.
Publicado: (2021)

Contrast enhanced mammography in breast cancer surveillance
por: Elder, Kenneth, et al.
Publicado: (2023)

Simultaneous 18F-FDG PET/MRI Radiomics and Machine Learning Analysis of the Primary Breast Tumor for the Preoperative Prediction of Axillary Lymph Node Status in Breast Cancer
por: Romeo, Valeria, et al.
Publicado: (2023)

Contrast-Enhanced Spectral Mammography: Comparison with Conventional Mammography and Histopathology in 152 Women
por: Luczyńska, Elzbieta, et al.
Publicado: (2014)

Contrast-enhanced mammography: what the radiologist needs to know
por: Neeter, Lidewij M.F.H., et al.
Publicado: (2021)

Enhancement Patterns in Contrast Mammography – A Pictorial Essay
por: Peters, Gesine, et al.
Publicado: (2021)

A simple classification system (the Tree flowchart) for breast MRI can reduce the number of unnecessary biopsies in MRI-only lesions
por: Woitek, Ramona, et al.
Publicado: (2017)

Automated Detection and Segmentation of Nonmass-Enhancing Breast Tumors with Dynamic Contrast-Enhanced Magnetic Resonance Imaging
por: Illan, Ignacio Alvarez, et al.
Publicado: (2018)

Quantitative Analysis of Enhancement Intensity and Patterns on Contrast-enhanced Spectral Mammography
por: Liu, Ying, et al.
Publicado: (2020)

AI-enhanced simultaneous multiparametric (18)F-FDG PET/MRI for accurate breast cancer diagnosis
por: Romeo, V., et al.
Publicado: (2021)

Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology—preliminary results
por: Rudnicki, Wojciech, et al.
Publicado: (2019)

A Simultaneous Multiparametric (18)F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer
por: Romeo, Valeria, et al.
Publicado: (2022)

Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer"
por: Deutschmann, Christine, et al.
Publicado: (2023)

Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography
por: Łuczyńska, Elżbieta, et al.
Publicado: (2015)

Contrast-enhanced spectral mammography with a compact synchrotron source
por: Heck, Lisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0amfca72p9thebruu2m8j4hpbn